Hungarian competition authorities have reportedly raided the local offices of French pharmaceutical conglomerate Sanofi in part of an investigation into suspicions that the company abused its market dominance.
Reports say the competition regulator GVH searched the offices on July 22; Sanofi confirmed the searches and said the company is fully cooperating with the investigation.
The GVH’s raids mark the launch of an investigation into concerns that the company abused its market power in regards to its wholesale trade contracts. Authorities said Sanofi refused to sign a contract with a Hungarian wholesale drug company. In a statement, GVH said that Sanofi’s practices to choose wholesale partners “is not based on the expected real economic efficiency of the link, while putting certain groups of market players into unjustified disadvantageous position relative to incumbent market players.”
Full content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan